The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells
Open accessAbstract
mTORC1 (mammalian target of rapamycin complex 1) controls transcriptional programs that determine CD8+ cytolytic T cell (CTL) fate. In some cell systems, mTORC1 couples phosphatidylinositol-3 kinase (PI3K) and Akt to the control of glucose uptake and glycolysis. However, PI3K–Akt-independent mechanisms control glucose metabolism in CD8+ T cells, and the role of mTORC1 has not been explored. The present study now demonstrates that mTORC1 activity in CD8+ T cells is not dependent on PI3K or Akt but is critical to sustain glucose uptake and glycolysis in CD8+ T cells. We also show that PI3K- and Akt-independent pathways mediated by mTORC1 regulate the expression of HIF1 (hypoxia-inducible factor 1) transcription factor complex. This mTORC1–HIF1 pathway is required to sustain glucose metabolism and glycolysis in effector CTLs and strikingly functions to couple mTORC1 to a diverse transcriptional program that controls expression of glucose transporters, multiple rate-limiting glycolytic enzymes, cytolytic effector molecules, and essential chemokine and adhesion receptors that regulate T cell trafficking. These data reveal a fundamental mechanism linking nutrient and oxygen sensing to transcriptional control of CD8+ T cell differentiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“D-2-HG activates NF-κB in bone marrow stromal cells in an IκB kinase-independent fashion, thus generating a stromal niche for IDH mutant AML development138.”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [138]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn923 · Cited by 14,108
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365
The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation
Wang, R., Dillon, C. P., Shi, L. Z., Milasta, S., Carter, R., Finkelstein, D., McCormick, L. L., Fitzgerald, P., Chi, H., Munger, J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.021 · Cited by 2,140 · cited 4×
“In this respect, a previous study has implicated c-myc as a major regulator of glucose metabolism in T cells (Wang et al., 2011).”
BackgroundInfluentialShi, L. Z., Wang, R., Huang, G., Vogel, P., Neale, G., Green, D. R., & Chi, H. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110278 · Cited by 1,803
mTOR regulates memory CD8 T-cell differentiation
Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bachmann, M. F., Larsen, C. P., & Ahmed, R. (2009) · Nature · doi:10.1038/nature08155 · Cited by 1,575
HIF-1: upstream and downstream of cancer metabolism
Semenza, G. L. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.10.009 · Cited by 1,431
Delgoffe, G. M., Pollizzi, K. N., Waickman, A. T., Heikamp, E., Meyers, D. J., Horton, M. R., Xiao, B., Worley, P. F., & Powell, J. D. (2011) · Nature Immunology · doi:10.1038/ni.2005 · Cited by 1,141
Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen
Pircher, H., Bürki, K., Lang, R., Hengartner, H., & Zinkernagel, R. M. (1989) · Nature · doi:10.1038/342559a0 · Cited by 1,019
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 596
de Silly, R. V., Ducimetière, L., Maroun, C. Y., Dietrich, P., Derouazi, M., & Walker, P. R. (2015) · European Journal of Immunology · doi:10.1002/eji.201445284 · Cited by 62
Kim, J. H., Han, J. W., Choi, Y. J., Rha, M.-S., Koh, J. Y., Kim, K. H., Kim, C. G., Lee, Y. J., Kim, A. R., Park, J., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.01.010 · Cited by 61
Reenergizing T cell anti-tumor immunity by harnessing immunometabolic checkpoints and machineries
Ho, P., & Kaech, S. M. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.04.003 · Cited by 62
Metabolic Adaptations of CD4+ T Cells in Inflammatory Disease
Dumitru, C., Kabat, A. M., & Maloy, K. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00540 · Cited by 65
Ren, L., Zhang, W., Han, P., Zhang, J., Zhu, Y., Meng, X., Zhang, J., Hu, Y., Yi, Z., & Wang, R. (2019) · Virology · doi:10.1016/j.virol.2019.02.010 · Cited by 58
Environmental and Metabolic Sensors That Control T Cell Biology
Ramsay, G., & Cantrell, D. A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00099 · Cited by 59
Self-citationFormate Supplementation Enhances Antitumor CD8+ T-cell Fitness and Efficacy of PD-1 Blockade
Rowe, J. H., Elia, I., Shahid, O., Gaudiano, E. F., Sifnugel, N. E., Johnson, S., Reynolds, A. G., Fung, M. E., Joshi, S., LaFleur, M. W., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-1301 · Cited by 59
mTOR and metabolic regulation of conventional and regulatory T cells
Liu, C., Chapman, N. M., Karmaus, P. W. F., Zeng, H., & Chi, H. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.2ri0814-408r · Cited by 59
Akt signaling is critical for memory CD8 + T-cell development and tumor immune surveillance
Rogel, A., Willoughby, J. E., Buchan, S. L., Leonard, H. J., Thirdborough, S. M., & Al‐Shamkhani, A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611299114 · Cited by 58
Turbitt, W. J., Rosean, C. B., Weber, K. S., & Norian, L. A. (2020) · Immunological Reviews · doi:10.1111/imr.12849 · Cited by 61
Modulation of asymmetric cell division as a mechanism to boost CD8 + T cell memory
Borsa, M., Barnstorf, I., Baumann, N. S., Pallmer, K., Yermanos, A., Gräbnitz, F., Barandun, N., Hausmann, A., Sandu, I., Barral, Y., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aav1730 · Cited by 58
Mesenchymal Stromal Cells Disrupt mTOR-Signaling and Aerobic Glycolysis During T-Cell Activation
Böttcher, M., Hofmann, A. D., Bruns, H., Haibach, M., Loschinski, R., Saul, D., Mackensen, A., Blanc, K. L., Jitschin, R., & Mougiakakos, D. (2015) · Stem Cells · doi:10.1002/stem.2234 · Cited by 59
Oxygen Levels and Immunological Studies
Zenewicz, L. A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00324 · Cited by 55
Hasan, F., Chiu, Y., Shaw, R., Wang, J., & Yee, C. (2021) · JCI Insight · doi:10.1172/jci.insight.138970 · Cited by 56
A central role for STAT5 in the transcriptional programing of T helper cell metabolism
Villarino, A. V., Laurence, A. D. J., Davis, F. P., Nivelo, L. A., Brooks, S. R., Sun, H., Jiang, K., Afzali, B., Frasca, D., Hennighausen, L. G., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abl9467 · Cited by 56
MicroRNAs and metabolic disorders – where are we heading?
Śliwińska, A., Kasińska, M., & Drzewoski, J. (2017) · Archives of Medical Science · doi:10.5114/aoms.2017.65229 · Cited by 55
mTOR signaling in immune cells and its implications for cancer immunotherapy
Zeng, H. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.08.038 · Cited by 54
Nicoli, F., Papagno, L., Frere, J. J., Cabral-Piccin, M. P., Clave, E., Emma Gostick, D., Toubert, A., Price, D. A., Caputo, A., & Appay, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02736 · Cited by 57
The Role of Metabolic Dysfunction in T-Cell Exhaustion During Chronic Viral Infection
Zheng, K., Zheng, X., & Yang, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.843242 · Cited by 56
Metabolic regulation of T cell differentiation and function
Park, B. V., & Pan, F. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.07.027 · Cited by 58
Witard, O. C., Turner, J. E., Jackman, S. R., Kies, A. K., Jeukendrup, A. E., Bosch, J. A., & Tipton, K. D. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.10.002 · Cited by 54
Proteasome activity regulates CD8+ T lymphocyte metabolism and fate specification
Widjaja, C. E., Olvera, J. G., Metz, P. J., Phan, A. T., Savas, J. N., de Bruin, G., Leestemaker, Y., Berkers, C. R., de Jong, A., Florea, B. I., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90895 · Cited by 56
Control of T Cell Metabolism by Cytokines and Hormones
Bishop, E. L., Gudgeon, N. H., & Dimeloe, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.653605 · Cited by 56
Stem cell like memory T cells: A new paradigm in cancer immunotherapy
Wang, F., Cheng, F., & Fang, Z. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109078 · Cited by 53
Voisinne, G., Locard‐Paulet, M., Froment, C., Maturin, E., Menoita, M. G., Girard, L., Mellado, V., Burlet‐Schiltz, O., MALISSEN, B., de Peredo, A. G., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01288-x · Cited by 53
Oxygen levels at the time of activation determine T cell persistence and immunotherapeutic efficacy
Cunha, P. P., Minogue, E., Krause, L. C. M., Hess, R. M., Bargiela, D., Wadsworth, B. J., Barbieri, L., Brombach, C., Foskolou, I. P., Bogeski, I., et al. (2023) · eLife · doi:10.7554/elife.84280 · Cited by 54
Ito, D., Nojima, S., Nishide, M., Okuno, T., Takamatsu, H., Kang, S., Kimura, T., Yoshida, Y., Morimoto, K., Maeda, Y., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403038 · Cited by 53
Targeting mTOR and Glycolysis in HER2-Positive Breast Cancer
Holloway, R. W., & Marignani, P. A. (2021) · Cancers · doi:10.3390/cancers13122922 · Cited by 56
Modified Hypoxia-Inducible Factor Expression in CD8+ T Cells Increases Antitumor Efficacy
Veliça, P., Cunha, P. P., Vojnovic, N., Foskolou, I. P., Bargiela, D., Gojkovic, M., Rundqvist, H., & Johnson, R. S. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0561 · Cited by 52
“Once released from VHL/PHD and FIH repression, HIF proteins heterodimerize with Aryl hydrocarbon Receptor Nuclear Translocator (ARNT), translocate to the nucleus, bind hypoxia-responsive elements (HRE) and initiate transcription of target genes.”
BackgroundInfluentialWu, J., Ma, S., Sandhoff, R., Ming, Y., Hotz‐Wagenblatt, A., Timmerman, V., Bonello‐Palot, N., Schlotter‐Weigel, B., Auer‐Grumbach, M., Seeman, P., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.005 · Cited by 52
FasL-PDPK1 Pathway Promotes the Cytotoxicity of CD8+ T Cells During Ischemic Stroke
Fan, L., Zhang, C., Zhu, L., Chen, J., Zhang, Z., Liu, P., Cao, X., Meng, H., & Xu, Y. (2020) · Translational Stroke Research · doi:10.1007/s12975-019-00749-0 · Cited by 51
Falasca, M., & Fyffe, C. (2013) · Cancer Management and Research · doi:10.2147/cmar.s35026 · Cited by 54
mTOR: A double-edged sword for diabetes
Tuo, Y., & Xiang, M. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0317-095rr · Cited by 50
Mousset, C. M., Hobo, W. A., Ji, Y., Fredrix, H., Giorgi, V. D., Allison, R. D., Kester, M. G. D., Falkenburg, J. H. F., Schaap, N. P., Jansen, J. H., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1488565 · Cited by 51
Targeting metabolic dysfunction of CD8 T cells and natural killer cells in cancer
Viel, S., Vivier, É., Walzer, T., & Marçais, A. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01098-w · Cited by 53
Wang, R., Zhuang, J., Zhang, Q., Wu, W., Yu, X., Zhang, H., & Xie, Z. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00689-6 · Cited by 52
mTOR Regulation of Lymphoid Cells in Immunity to Pathogens
Keating, R., & McGargill, M. A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00180 · Cited by 50
Akbarpour, M., Khalyfa, A., Qiao, Z., Gileles‐Hillel, A., Almendros, I., Farré, R., & Gozal, D. (2016) · SLEEP · doi:10.1093/sleep/zsw040 · Cited by 49
Bridging angiogenesis and immune evasion in the hypoxic tumor microenvironment
Schito, L. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00209.2018 · Cited by 49
T cell-specific deletion of Pgam1 reveals a critical role for glycolysis in T cell responses
Toriyama, K., Kuwahara, M., Kondoh, H., Mikawa, T., Takemori, N., Konishi, A., Yorozuya, T., Yamada, T., Soga, T., Shiraishi, A., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-01122-w · Cited by 51
In vivo CRISPR screens reveal a HIF-1α-mTOR-network regulates T follicular helper versus Th1 cells
Huang, B., Phelan, J. D., Preite, S., Gómez‐Rodríguez, J., Johansen, K. H., Shibata, H., Shaffer, A. L., Xu, Q., Jeffrey, B. M., Kirby, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28378-6 · Cited by 48
CD8+ T cells in brain injury and neurodegeneration
Zhang, Z., Duan, Z., & Cui, Y. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1281763 · Cited by 51
Cancer, obesity and immunometabolism – Connecting the dots
Dyck, L., & Lynch, L. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.12.019 · Cited by 48
Ruscogenin suppressed the hepatocellular carcinoma metastasis via PI3K/Akt/mTOR signaling pathway
Hua, H., Zhu, Y. X., & Song, Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.031 · Cited by 47
Metabolic Checkpoints in Differentiation of Helper T Cells in Tissue Inflammation
Roy, S., Rizvi, Z. A., & Awasthi, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03036 · Cited by 50
Zeng, H., Yu, M., Tan, H., Li, Y., Su, W., Shi, H., Dhungana, Y., Guy, C. S., Neale, G. A. M., Cloer, C., et al. (2018) · Science Advances · doi:10.1126/sciadv.aar5701 · Cited by 48
Preite, S., Huang, B., Cannons, J. L., McGavern, D. B., & Schwartzberg, P. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03079 · Cited by 45
Liu, G., Bi, Y., Wang, R., Yang, H., Zhang, Y., Wang, X. D., Liu, H., Lu, Y., Zhang, Z., Chen, W., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301193 · Cited by 45
mTOR signaling and transcriptional regulation in T lymphocytes
Zeng, H., & Chi, H. (2014) · Transcription · doi:10.4161/trns.28263 · Cited by 45
Sugar or Fat?—Metabolic Requirements for Immunity to Viral Infections
Shehata, H. M., Murphy, A. J., Lee, M. K. S., Gardiner, C. M., Crowe, S. M., Sanjabi, S., Finlay, D. K., & Palmer, C. S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01311 · Cited by 47
Self-citationAnderson, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010141 · Cited by 45
Fatty acid metabolism in T-cell function and differentiation
Endo, Y., Kanno, T., & Nakajima, T. (2022) · International Immunology · doi:10.1093/intimm/dxac025 · Cited by 52
Cell metabolism-based optimization strategy of CAR-T cell function in cancer therapy
Li, W., Pan, X., Chen, L., Cui, H., Mo, S., Pan, Y., Shen, Y., Shi, M., Wu, J., Luo, F., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1186383 · Cited by 49
Report of a Chinese Cohort with Activated Phosphoinositide 3-Kinase δ Syndrome
Wang, Y., Wang, W., Liu, L., Hou, J. W., Ying, W., Hui, X., Zhou, Q., Liu, D., Yao, H., Sun, J., et al. (2018) · Journal of Clinical Immunology · doi:10.1007/s10875-018-0568-x · Cited by 44
Role of HIF1 α Regulatory Factors in Stem Cells
Lee, H. J., Jung, Y. H., Choi, G. E., Kim, J. S., Chae, C. W., & Han, H. J. (2019) · International Journal of Stem Cells · doi:10.15283/ijsc18109 · Cited by 45
Tan, S. Y., Kelkar, Y., Hadjipanayis, A. G., Shipstone, A., Wynn, T. A., & Hall, J. P. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000137 · Cited by 46
Implications of cellular metabolism for immune cell migration
Guak, H., & Krawczyk, C. M. (2020) · Immunology · doi:10.1111/imm.13260 · Cited by 47
Serine Metabolic Reprogramming in Tumorigenesis, Tumor Immunity, and Clinical Treatment
Wang, S., Xiaoxue, Y., Guanbin, S., Yang, L., Junyu, J., & Liu, W. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.05.007 · Cited by 47
More TOR: The expanding role of mTOR in regulating immune responses
Patel, C. H., & Powell, J. D. (2025) · Immunity · doi:10.1016/j.immuni.2025.06.010 · Cited by 48
Kapnick, S. M., Stinchcombe, J. C., Griffiths, G. M., & Schwartzberg, P. L. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601202 · Cited by 43
Franco, J. L. M., Genoula, M., Corral, D., Duette, G., Ferreyra, M., Maio, M., Dolotowicz, M. B., Aparicio‐Trejo, O. E., Patiño‐Martínez, E., Charton, A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108547 · Cited by 41
T-cell dysfunction in chronic lymphocytic leukemia from an epigenetic perspective
Peters, F. S., Strefford, J. C., Eldering, E., & Kater, A. P. (2021) · Haematologica · doi:10.3324/haematol.2020.267914 · Cited by 43
Adenosine-Mono-Phosphate-Activated Protein Kinase-Independent Effects of Metformin in T Cells
Zarrouk, M., Finlay, D. K., Foretz, M., Viollet, B., & Cantrell, D. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106710 · Cited by 44
Self-citationInsulin Promotes Glucose Consumption via Regulation of miR-99a/mTOR/PKM2 Pathway
Li, W., Wang, J., Chen, Q.-D., Qian, X., Li, Q., Yin, Y., Shi, Z., Wang, L., Lin, J., Liu, L.-Z., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064924 · Cited by 41
Common gamma chain cytokines and CD8 T cells in cancer
Shourian, M., Beltra, J., Bourdin, B., & Decaluwe, H. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.101307 · Cited by 43
The kinase PDK1 is critical for promoting T follicular helper cell differentiation
Sun, Z., Yao, Y., You, M., Liu, J., Guo, W., Qi, Z., Wang, Z., Wang, F., Yuan, W., & Yu, S. (2021) · eLife · doi:10.7554/elife.61406 · Cited by 41
Nanjappa, S. G., McDermott, A. J., Fites, J. S., Galles, K., Wüthrich, M., Deepe, G. S., & Klein, B. S. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006356 · Cited by 42
Liu, Y., Yan, H., Gu, H., Zhang, E., He, J., Cao, W., Qu, J., Xu, R., Cao, L., He, D., et al. (2022) · OncoImmunology · doi:10.1080/2162402x.2022.2057837 · Cited by 39
To breathe or not to breathe: Understanding how oxygen sensing contributes to age-related phenotypes
van Vliet, T., Casciaro, F., & Demaria, M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101267 · Cited by 41
T cell metabolism and the immune response
Verbist, K., Wang, R., & Green, D. R. (2012) · Seminars in Immunology · doi:10.1016/j.smim.2012.12.006 · Cited by 41
Modulation of CD4 T Cell Response According to Tumor Cytokine Microenvironment
Accogli, T., Bruchard, M., & Végran, F. (2021) · Cancers · doi:10.3390/cancers13030373 · Cited by 43
Perspectives on Hypoxia Signaling in Tumor Stroma
Zhang, Y., Coleman, M., & Brekken, R. A. (2021) · Cancers · doi:10.3390/cancers13123070 · Cited by 39
Wang, H., Liu, S., Sun, Y., Chen, C., Hu, Z., Li, Q., Long, J., Yan, Q., Liang, J., Lin, Y., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102472 · Cited by 39
Swan, D. J., Aschenbrenner, D., Lamb, C. A., Chakraborty, K., Clark, J. P., Pandey, S., Engelhardt, K. R., Chen, R., Cavounidis, A., Ding, Y., et al. (2019) · Haematologica · doi:10.3324/haematol.2018.208397 · Cited by 39
Self-citationTissue-Resident Memory T Cells in the Liver—Unique Characteristics of Local Specialists
Bartsch, L. M., Damasio, M. P. S., Subudhi, S., & Drescher, H. K. (2020) · Cells · doi:10.3390/cells9112457 · Cited by 44
Lim, S. A., Moon, Y., Shin, M. H., Kim, T.-J., Chae, S., Yee, C., Hwang, D., Park, H., & Lee, K. (2021) · Cancers · doi:10.3390/cancers13081904 · Cited by 39
The kinase PDK1 regulates regulatory T cell survival via controlling redox homeostasis
Feng, P., Yang, Q., Luo, L., Sun, Y., Lv, W., Wan, S., Guan, Z., Xiao, Z., Liu, F., Li, Z., et al. (2021) · Theranostics · doi:10.7150/thno.63992 · Cited by 39
Proliferation Conditions Promote Intrinsic Changes in NK Cells for an IL-10 Response
Tarrio, M. L., Lee, S., Fragoso, M. F., Sun, H., Kanno, Y., O’Shea, J. J., & Biron, C. A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302999 · Cited by 39
Cannons, J. L., Preite, S., Kapnick, S. M., Uzel, G., & Schwartzberg, P. L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01758 · Cited by 37
Murthy, A., Gerber, S. A., Koch, C. J., & Lord, E. M. (2019) · ImmunoHorizons · doi:10.4049/immunohorizons.1900017 · Cited by 36
Targeting of chimeric antigen receptor T cell metabolism to improve therapeutic outcomes
Nanjireddy, P., Olejniczak, S. H., & Buxbaum, N. P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1121565 · Cited by 39
PI3Kδ Regulates the Magnitude of CD8+ T Cell Responses after Challenge with Listeria monocytogenes
Pearce, V. Q., Bouabe, H., MacQueen, A. R., Carbonaro, V., & Okkenhaug, K. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501227 · Cited by 36
Self-citationStrategies to Overcome Failures in T-Cell Immunotherapies by Targeting PI3K-δ and –γ
Chandrasekaran, S., Funk, C. R., Kleber, T. J., Paulos, C. M., Shanmugam, M., & Waller, E. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.718621 · Cited by 36
Benesova, K., Kraus, F. V., Carvalho, R. A., Lorenz, H., Hoerth, C. H., Günther, J., Klika, K. D., Graf, J., Diekmann, L., Schank, T. E., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-222451 · Cited by 39
Vallet, N., Grand, S. L., Bondeelle, L., Hoareau‐Coudert, B., Corneau, A., Bouteiller, D., Tournier, S., Lew‐Derivry, L., Bohineust, A., Tourret, M., et al. (2022) · Blood · doi:10.1182/blood.2022016926 · Cited by 37
Metabolic signatures of immune cells in chronic kidney disease
Li, J., Yang, Y., Wang, Y., Li, Q., & He, F. (2022) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.35 · Cited by 36
Sivanandan, S., Leitmann, B., Lubeck, E., Sultan, M. M., Stanitsas, P., Ranu, N., Ewer, A., Mancuso, J. E., Phillips, Z. F., Kim, A. M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66778-6 · Cited by 44
Mu, Q., Jiang, M., Zhang, Y., Wu, F., Li, H. Z., Zhang, W., Wang, F., Liu, J., Li, L., Wang, D., et al. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s154853 · Cited by 36
Hematopoietic versus Solid Cancers and T Cell Dysfunction: Looking for Similarities and Distinctions
Montironi, C., Muñoz‐Pinedo, C., & Eldering, E. (2021) · Cancers · doi:10.3390/cancers13020284 · Cited by 38
Sensing the oxygen and temperature in the adipose tissues – who’s sensing what?
Kang, G.-S., Jo, H.-J., Lee, Y.-R., Oh, T., Park, H.-J., & Ahn, G. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01113-x · Cited by 36
The emerging role of mTOR signalling in antibacterial immunity
Abdel‐Nour, M., Tsalikis, J., Kleinman, D. R., & Girardin, S. E. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2014.3 · Cited by 33
Intestinal oxygen utilisation and cellular adaptation during intestinal ischaemia–reperfusion injury
Barakakis, P. A., Mavridis, T., Chlorogiannis, D., Barakakis, G., Laou, E., Sessler, D. I., Gkiokas, G., & Chalkias, A. F. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.70136 · Cited by 32
Rouquette‐Jazdanian, A. K., Kortum, R. L., Li, W., Merrill, R. K., Nguyen, P. H., Samelson, L. E., & Sommers, C. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131823 · Cited by 33
Mammalian target of rapamycin controls glucose consumption and redox balance in human Sertoli cells
Jesus, T. T., Oliveira, P. F., Silva, J., Barros, A., Ferreira, R. M., Sousa, M., Cheng, C. Y., Silva, B. M., & Alves, M. G. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.11.032 · Cited by 33
Lo, Y.-C., Lee, C.-F., & Powell, J. D. (2014) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000098 · Cited by 33
Therapeutic potential of aryl hydrocarbon receptor in autoimmunity
Wang, X., Cao, F., Zhang, Y., & Pan, H. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00651-z · Cited by 33
Wang, Z., Li, B., Jiang, H., Ma, Y., Bao, Y., Zhu, X., Xia, H., & Jin, Y. J. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155402 · Cited by 32
Cannons, J. L., Villarino, A. V., Kapnick, S. M., Preite, S., Shih, H., Gómez‐Rodríguez, J., Kaul, Z., Shibata, H., Reilley, J. M., Huang, B., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109804 · Cited by 31
Shehata, H. M., Khan, S., Chen, E., Fields, P. E., Flavell, R. A., & Sanjabi, S. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1808320115 · Cited by 31
Deng, S., Wang, S., Shi, X., & Zhou, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168940 · Cited by 35
Metadata
- Authors
- Finlay, D. K., Rosenzweig, E., Sinclair, L. V., Feijoo-Carnero, C., Hukelmann, J. L., Rolf, J., Panteleyev, A. A., Okkenhaug, K., & Cantrell, D. A.
- Affiliations
- Trinity College Dublin (IE)
- University of Dundee (GB)
- Division of Cell Signalling and Immunology, College of Life Sciences 3 ; and 4
- Babraham Institute (GB)
- Corresponding author
- Finlay, David K.
- Cantrell, Doreen A.
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2012-11-26
- Volume
- 209
- Issue
- 13
- Pages
- 2441-2453
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC3526360
- OpenAlex
- W2164164239
- Cited by
- 596
- References
- 35
- Citations by year
- 2026: 29 · 2025: 33 · 2024: 32 · 2023: 43 · 2022: 46 · 2021: 59 · 2020: 47 · 2019: 56 · 2018: 45 · 2017: 43 · 2016: 49 · 2015: 46 · 2014: 36 · 2013: 29 · 2012: 2
- FWCI
- 14.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (acceptedVersion, other-oa)
- Arrow@dit (Dublin Institute of Technology) (acceptedVersion)
- Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion, cc-by-nc-sa)
- Apollo (University of Cambridge) (submittedVersion, cc-by-nc-sa)
- Apollo
- Funders
- University of Dundee
- Wellcome Trust (097418/Z/11/Z, 095691, 065975, 097418)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- mTORC1, CD8+ T cells, cytotoxic T lymphocytes, HIF-1, glucose metabolism, glycolysis, glucose uptake, T cell migration, T cell differentiation, nutrient sensing, oxygen sensing, glucose transporters, chemokine receptors, cell adhesion receptors
- MeSH terms
- Mechanistic Target of Rapamycin Complex 1, Animals, Cell Differentiation, Cell Movement, Gene Expression Regulation, Glucose, Glycolysis, Interleukin-2, Mice, Inbred C57BL, Mice, Mutant Strains, Mice, Transgenic, Proteins, Receptors, Antigen, T-Cell, Protein Serine-Threonine Kinases, CD8-Positive T-Lymphocytes, Chemokines, Receptors, Chemokine, Phosphatidylinositol 3-Kinases, Multiprotein Complexes, Proto-Oncogene Proteins c-akt, Mice, Aryl Hydrocarbon Receptor Nuclear Translocator, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit, TOR Serine-Threonine Kinases, 3-Phosphoinositide-Dependent Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review